Replies to post #20584 on NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

They also target different types of cancer. DCVax is for solid tumors and paths approach Novartis and Juno are for blood cancers.

[Evaluate]

Did you also see this regarding CAR therapies?

While most analysts think it is too early to estimate potential revenue or price, Citigroup believes CAR therapies could cost in excess of $500,000 per patient, which it notes is roughly in line with the cost of a stem cell transplant.

This makes the DCVax treatment of approx $110.000 per patient for a 3 year period seem "pretty reasonable".
Let's find out soon whether Germany agrees.


But, then there is also this:

Dr. Kantarjian says one thing that has to change is the law that prevents Medicare from negotiating for lower prices.
Dr. Hagop Kantarjian: This is unique to the United States. If you look anywhere in the world, there are negotiations. Either by the government or by different regulatory bodies to regulate the price of the drug. And this is why the prices are 50 percent to 80 percent lower anywhere in the world compared to the United States.